skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Biological And Medical Sciences remover assunto: Gynecology. Andrology. Obstetrics remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

DE AZAMBUJA, E ; CARDOSO, F ; DE CASTRO JR, G ; COLOZZA, M ; MANO, M. S ; DURBECQ, V ; SOTIRIOU, C ; LARSIMONT, D ; PICCART-GEBHART, M. J ; PAESMANS, M

British journal of cancer, 2007-05, Vol.96 (10), p.1504-1513 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Colozza, M. ; Azambuja, E. ; Cardoso, F. ; Sotiriou, C. ; Larsimont, D. ; Piccart, M. J.

Annals of oncology, 2005-11, Vol.16 (11), p.1723-1739 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Small breast cancers: When and how to treat
Small breast cancers: When and how to treat
Material Type:
Artigo 		Adicionar ao Meu Espaço

Small breast cancers: When and how to treat

Tryfonidis, K ; Zardavas, D ; Cardoso, F

Cancer treatment reviews, 2014-12, Vol.40 (10), p.1129-1136 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

Gancberg, D. ; Di Leo, A. ; Cardoso, F. ; Rouas, G. ; Pedrocchi, M. ; Paesmans, M. ; Verhest, A. ; Bernard-Marty, C. ; Piccart, M. J. ; Larsimont, D.

Annals of oncology, 2002-07, Vol.13 (7), p.1036-1043 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Viale, G. ; Slaets, L. ; Bogaerts, J. ; Rutgers, E. ; van't Veer, L. ; Piccart-Gebhart, M.J. ; de Snoo, F.A. ; Stork-Sloots, L. ; Russo, L. ; Dell'Orto, P. ; van den Akker, J. ; Glas, A. ; Cardoso, F.

Annals of oncology, 2014-04, Vol.25 (4), p.816-823 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

KNAUER, M ; CARDOSO, F ; WESSELING, J ; BEDARD, P. L ; LINN, S. C ; RUTGERS, Ejt ; VAN 'T VEER, L. J

British journal of cancer, 2010-12, Vol.103 (12), p.1788-1793 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

Annals of oncology, 2013-12, Vol.24 (12), p.2985-2989 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Cardoso, F. ; Costa, A. ; Norton, L. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Biganzoli, L. ; Blackwell, K.L. ; Cardoso, M.J. ; Cufer, T. ; El Saghir, N. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Giordano, S.H. ; Gligorov, J. ; Goldhirsch, A. ; Harbeck, N. ; Houssami, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Kyriakides, S. ; Lin, U.N. ; Mayer, M. ; Merjaver, S.D. ; Nordström, E.B. ; Pagani, O. ; Partridge, A. ; Penault-Llorca, F. ; Piccart, M.J. ; Rugo, H. ; Sledge, G. ; Thomssen, C. ; van't Veer, L. ; Vorobiof, D. ; Vrieling, C. ; West, N. ; Xu, B. ; Winer, E.

Annals of oncology, 2014-10, Vol.25 (10), p.1871-1888 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer

Azambuja, E. ; Durbecq, V. ; Rosa, D. D. ; Colozza, M. ; Larsimont, D. ; Piccart-Gebhart, M. ; Cardoso, F.

Annals of oncology, 2008-02, Vol.19 (2), p.223-232 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer

Atalay, G. ; Cardoso, F. ; Awada, A. ; Piccart, M. J.

Annals of oncology, 2003-09, Vol.14 (9), p.1346-1363 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (60)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1987  (4)
  2. 1987Até2000  (4)
  3. 2001Até2004  (12)
  4. 2005Até2008  (18)
  5. Após 2008  (24)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.